<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">mvjr</journal-id><journal-title-group><journal-title xml:lang="en">Medical Herald of the South of Russia</journal-title><trans-title-group xml:lang="ru"><trans-title>Медицинский вестник Юга России</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2219-8075</issn><issn pub-type="epub">2618-7876</issn><publisher><publisher-name>The Rostov State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2219-8075-2022-13-2-50-58</article-id><article-id custom-type="elpub" pub-id-type="custom">mvjr-1551</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>OBSTETRICS AND GYNECOLOGY</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>АКУШЕРСТВО И ГИНЕКОЛОГИЯ</subject></subj-group></article-categories><title-group><article-title>Microbiota of the vagina and myoma nodes in uterine myoma</article-title><trans-title-group xml:lang="ru"><trans-title>Микробиота влагалища и миоматозных узлов при миоме матки</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7253-5619</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никитина</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikitina</surname><given-names>E. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Никитина Екатерина Сергеевна, к.м.н., ассистент кафедры акушерства и гинекологии №1</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Ekaterina S. Nikitina, Cand. Sci. (Med.), Assistant of the Department of Obstetrics and Gynecology No. 1 </p><p>Rostov-on-Don</p></bio><email xlink:type="simple">sebfontaine@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3349-6914</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рымашевский</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Rymashevsky</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Рымашевский Александр Николаевич, д.м.н., проф., заведующий кафедрой акушерства и гинекологии №1</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Alexander N. Rymashevsky, Dr. Sci. (Med.), professor, Head of the Department of Obstetrics and Gynecology No. 1 </p><p>Rostov-on-Don</p></bio><email xlink:type="simple">rymashevskyan@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0937-4573</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Набока</surname><given-names>Ю. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Naboka</surname><given-names>Y. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Набока Юлия Лазаревна, д.м.н., проф., заведующая кафедрой микробиологии и вирусологии №1</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Yulia L. Naboka, Dr. Sci. (Med.), Professor, head of Department of microbiology and virology №1 </p><p>Rostov-on-Don</p></bio><email xlink:type="simple">nagu22@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4547-4459</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рымашевский</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Rymashevsky</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Рымашевский Михаил Александрович, к.м.н., ассистент кафедры акушерства и гинекологии №1</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Mikhail A. Rymashevsky, Cand. Sci. (Med.), Assistant of the Department of Obstetrics and Gynecology No. 1 </p><p>Rostov-on-Don</p></bio><email xlink:type="simple">mikhail.rymashevskiy@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0995-7848</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гудима</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gudima</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гудима Ирина Александровна, д.м.н., доц., профессор кафедры микробиологии и вирусологии №1</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Irina A. Gudima, Dr. Sci. (Med.), associate professor, professor of the Department of microbiology and virology №1 </p><p>Rostov-on-Don</p></bio><email xlink:type="simple">naguirina22@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0986-0608</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Свирава</surname><given-names>Э. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Svirava</surname><given-names>E. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Свирава Этери Гонериевна, к. м. н., ассистент кафедры микробиологии и вирусологии №1</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Eteri G. Svirava, Cand. Sci. (Med.), Assistant Professor of Microbiology and Virology Department No. 1 </p><p>Rostov-on-Don</p></bio><email xlink:type="simple">Svirava@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ростовский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Rostov State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>06</day><month>07</month><year>2022</year></pub-date><volume>13</volume><issue>2</issue><fpage>50</fpage><lpage>58</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Nikitina E.S., Rymashevsky A.N., Naboka Y.L., Rymashevsky M.A., Gudima I.A., Svirava E.G., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Никитина Е.С., Рымашевский А.Н., Набока Ю.Л., Рымашевский М.А., Гудима И.А., Свирава Э.Г.</copyright-holder><copyright-holder xml:lang="en">Nikitina E.S., Rymashevsky A.N., Naboka Y.L., Rymashevsky M.A., Gudima I.A., Svirava E.G.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medicalherald.ru/jour/article/view/1551">https://www.medicalherald.ru/jour/article/view/1551</self-uri><abstract><p>Objective: to study the microbiota of the vagina, myomatous nodes, their bed in patients with fibroids. Materials and methods: a comprehensive examination of 83 patients aged 26 to 50 years with diagnosed interstitial, interstitial-subserous uterine myoma was carried out. By age, all women are divided into 3 groups. Standard clinical and clinical laboratory studies, colposcopy, microbiological examination of the detachable posterior vaginal fornix, biopsy specimens of myomatous nodes and their bed, as well as morphological examination of biopsy specimens of myomatous nodes and their bed were performed.Results: in the structure of clinical manifestations of uterine fibroids, pain syndrome was the leading one (p&lt;0.05). The number of myoma nodes in patients varied from 1 to 22. The duration of the operation and the amount of blood loss did not differ significantly (p&gt;0.05). According to the results of a bacteriological study of the detachable posterior vaginal fornix in patients in the 2nd group, a decrease in the frequency of detection and the number of lactobacilli was revealed compared to the 1st group, and in women in the 3rd group, these microorganisms were absent. Among the anaerobic microorganisms in the 1st and 2nd groups, Eubacterium spp. dominated, in the 3rd — Peptostreptococcus spp. In patients of group 3, the frequency of detection of Bacteroides spp. was significantly increased (p&lt;0.05). Among the aerobic spectrum of microorganisms in all groups, coagulasenegative staphylococci predominated. In a bacteriological study of biopsy specimens, the absence of growth of microorganisms in myomatous nodes was observed in 7.2% of cases, in the tissue of the bed of myomatous nodes in 17.7%. The microbiota of myomatous nodes and their bed in most cases was represented by anaerobic taxa. According to the results of a morphological study of biopsy specimens, no inflammatory reaction of tissues was detected. Conclusions: In women with uterine myoma of different age groups, multidirectional changes in the vaginal microbiota were revealed. In most cases, the myomatous node (92.8%) and its bed (82.3%) are not sterile with the dominance of anaerobic microbiota taxa. Identified significant correlations in the loci «vagina – myomatous node – myomatous node bed» indicate their relationship. The detection of various taxa of microorganisms in the myomatous node and its bed, according to morphological studies, is not associated with the presence of infectious and inflammatory processes in the tissues.</p></abstract><trans-abstract xml:lang="ru"><p>Цель: изучить микробиоту влагалища, миоматозных узлов, их ложа у пациенток с миомой. Материалы и методы: проведено комплексное обследование 83 пациенток в возрасте от 26 до 50 лет с диагностированной интерстициальной, интерстициально-субсерозной миомой матки. По возрасту все женщины распределены на три группы. Были выполнены стандартные клинические и клинико-лабораторные исследования, кольпоскопия, микробиологическое исследование отделяемого заднего свода влагалища, биоптатов миоматозных узлов и их ложа, а также морфологическое исследование биоптатов миоматозных узлов и их ложа, полученных при оперативном лечении опухоли.Результаты: в структуре клинических проявлений миомы матки ведущим являлся болевой синдром. Количество миоматозных узлов у пациенток варьировалось от 1 до 22. Продолжительность операции и объём кровопотери в группах значимо не различались (p&gt;0,05). У пациенток II группы в отделяемом заднего свода влагалища выявлено снижение частоты обнаружения и количества лактобацилл по сравнению с I группой, а у женщин в III группе данные микроорганизмы отсутствовали. Среди анаэробных микроорганизмов в I и II группах доминировали Eubacterium spp., в III — Peptostreptococcus spp. У пациенток III группы значимо повышена (p&lt;0,05) частота обнаружения Bacteroides spp. Среди аэробного спектра микроорганизмов во всех группах преобладали коагулазоотрицательные стафилококки. При бактериологическом исследовании биоптатов отсутствие роста микроорганизмов в миоматозных узлах наблюдали в 7,2% случаев, в ткани ложа миоматозных узлов — в 17,7%. Микробиота миоматозных узлов и их ложа в большинстве случаев была представлена анаэробными таксонами. По результатам морфологического исследования биоптатов, воспалительной реакции тканей не выявлено. Выводы: У женщин с миомой матки различных возрастных групп выявлены разнонаправленные изменения в микробиоте влагалища. В большинстве случаев миоматозный узел (92,8%) и его ложе (82,3%) нестерильны с доминированием анаэробных таксонов микробиоты. Выявленные значимые корреляционные связи в локусах «влагалище – миоматозный узел – ложе миоматозного узла» свидетельствуют об их взаимосвязи. Обнаружение различных таксонов микроорганизмов в миоматозном узле и его ложе, по данным морфологических исследований, не сопряжены с наличием инфекционно-воспалительных процессов в тканях.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>миома матки</kwd><kwd>микрофлора</kwd><kwd>микробиота влагалища</kwd><kwd>микробиота миоматозного узла</kwd><kwd>микробиота&#13;
ложа миоматозного узла</kwd></kwd-group><kwd-group xml:lang="en"><kwd>uterine fibroids</kwd><kwd>microflora</kwd><kwd>vaginal microbiota</kwd><kwd>microbiota of the myomatous node</kwd><kwd>microbiota of the bed of the&#13;
myomatous node</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>Uterine fibroids (UFs) are the dominant pelvic tumor in all countries [1–9]. The etiology and pathogenesis of this pathology are not only the subject of close study but also a wide field for discussion. A number of studies proved the importance of sex hormones influencing the growth of myomatous nodes (MNs) [10–19]. Moreover, the role of estrogens and progesterone in the development of UFs is almost equivalent; however, there is variability in both clinical symptoms and the course of the disease [<xref ref-type="bibr" rid="cit10">10</xref>]. In particular, UFs in one and the same patient are often characterized by different rates of growth and/or regression in the presence of common effects of sex hormones [<xref ref-type="bibr" rid="cit20">20</xref>]. However, the role of angiogenesis and vascularization, which control tumor growth, cannot be ignored [<xref ref-type="bibr" rid="cit21">21</xref>]. The authors also discuss the importance of progenitor cells, the presence of which can lead to UF manifestation, in particular, stem cell (SSC) verification in myometrium [<xref ref-type="bibr" rid="cit22">22</xref>].</p><p>At present, the role of the microbial factor in the development of UFs is understudied. A few works on this issue [<xref ref-type="bibr" rid="cit23">23</xref>] suggest that infectious and inflammatory processes of the pelvic organs and uterine annexes may be the triggers of this pathology in some cases. Morphological examination of uterine preparations obtained from patients with a confirmed diagnosis of "endometritis" verifies the "rudiments" of MNs located around the inflammatory zone. DNA from chlamydia, mycoplasmas, or their combinations was detected in the biopsy specimens of MNs by PCR. Various disorders [<xref ref-type="bibr" rid="cit24">24</xref>] of the vaginal microbiocenosis may affect the development of UFs. However, there are almost no data on the MN microbiota and/or microbiome. It can be assumed that they have their own, unique microbial patterns, the presence of which does not determine the development of an inflammatory process in the uterus.</p><p>The study aimed to evaluate the microbiota of the vagina, MNs, and their bed in patients with fibroids.</p></sec><sec><title>Materials and Methods</title><p>The study was conducted based on the facilities of the Gynecology Department, Clinical Diagnostic Laboratory, Morphological Department of the Central Scientific-Research Laboratory, Departments of Obstetrics and Gynecology No. 1 and Microbiology and Virology No. 1 of RostMSU of the Ministry of Health of the Russian Federation in the period from 2016 to 2019. The study was approved by the local independent ethics committee (protocol No. 19/16 of October 4, 2016). The study design included a comprehensive examination of 83 women with diagnosed UFs aged 26 to 50 years old (mean age 36.6±0.8 years old).</p><p>Inclusion criteria were UFs diagnosed by bimanual and ultrasound examinations; interstitial, interstitial-subserosal localization of MNs; MNs ≥5 cm in size; the presence of menses; a patient's written consent to participate in the study.</p><p>Exclusion criteria were taking hormonal (within 6 months before the study) and antibacterial drugs (within 1 month before the study), pelvic cancer, and a patient's refusal to participate in the study.</p><p>Patients were divided by age into three groups. Group I (n=19) included patients aged 26–34 years old, Group II (n=48) –35–44 years old, and Group III (n=16) – 45-50 years old.</p><p>The office evaluation of the patients included standard clinical and clinical-laboratory examinations and simple and extended colposcopy.</p><p>According to Guideline 4.2.2039-05 (2006), the vaginal discharge from the posterior vaginal fornix (VDPVF) was taken from each patient 24 hours before the operation. Intraoperatively, biopsy specimens of MNs and their beds (MNBs) were also taken for microbiological examination. VDPVF specimens were taken with a sterile swab (Sterile Pure Viscose Swab w/Polypropylene Stick), placed in a medium (Hiculture Transport Swabs w/Alternative Thioglycollate Medium), and transported to the laboratory (30–60 min). The cultural study was performed according to the corresponding technique [<xref ref-type="bibr" rid="cit25">25</xref>] using nutrient media for both aerobic (MacConkey Agar, HiCrome Klebsiella Selective Agar Base, HiCrome Candida Differential Agar, HiCrome Enterococci Agar, HiCrome Aureus Agar Base, Blood Agar Base, Streptococcus Selection Agar) and anaerobic (dense nutrient media Bifidobacterium Agar, MRS Agar, Anaerobic Agar, Schaedler Agar, Bacteroides Bile Esculinum Agar, liquid – Shaedler Broth and semi-liquid Blaurock nutrient media) microbiota taxa. Cultivation was performed under aerobic (t -37 ºC, 24–48 h) and anaerobic (AnaeroHiGas Pak, t ‑37 ºC, 48–72 h) conditions. Identification of the isolated microorganisms was performed according to common methods.</p><p>Intraoperatively, biopsy samples (0.5×0.5 cm) of MNs and MNBs were taken into Eppendorf tubes containing thioglycolic buffer (1 ml) and transported to the laboratory for not more than 60 minutes. Then, the test material was homogenized (Becton Picrinson Mediamachine System). Bacteriological examination was performed on nutrient media for aerobic and anaerobic microorganisms described above under appropriate cultivation conditions. Identification of microorganisms isolated from biopsy specimens was also performed according to generally accepted methods.</p><p>The morphological examination was performed by the traditional method with the preparation of paraffin sections of the studied material (MNs, MNBs) and stained with hematoxylin-eosin and Van Gieson’s picrofuchsin. A microscope Micros (Austria) at 300× magnification was used for a microscopic study of the preparations.</p><p>A statistical analysis of the results was performed using the statistical processing and visualization environment R ver 3.2 (R Foundation for Statistical Computing, Vienna, Austria). The quantitative characteristics of microorganisms verified at different loci were presented as median and lower and upper quartiles (the Kruskal-Wallis test was used for comparison). Pearson’s c2 and Fisher’s tests were used to compare the reliability of differences. Spearman’s rank correlation coefficient was used to assess the closeness of the relationship between certain attributes.</p></sec><sec><title>Results</title><p>Pain syndrome dominated in the structure of clinical manifestations of UFs, which was more frequently (p&lt;0.05) registered in Group III patients (Figure 1). In the same group, dysuric disorders were detected in more than 1/3 of cases (p&lt;0.05).</p><fig id="fig-1"><caption><p>Рисунок 1. Значимые отличия в клинических проявлениях миомы матки у пациенток I–III групп</p><p>Figure 1. Significant differences in the clinical manifestations of uterine fibroids in patients of groups I–III.</p></caption><graphic xlink:href="mvjr-13-2-g001.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/mvjr/2022/2/135EWzRLYGFW0aio9Btjh3HkioeG7GcWBTwSZuXw.jpeg</uri></graphic></fig><p>The number of MNs in the patients of the studied groups ranged from min 1 to max 22. The mean numbers were 2.4±0.5 in Group I, 5.2±0.8 in Group II, and 3.3±0.6 in Group III. Multiple UFs were verified in 42.1% of the patients in Group I, 70.8% – in Group II, 81.3% – in Group III. In single UFs, the mean node size was 10.9±0.7 cm; in multiple UFs, the mean minimum node size was 2.3±0.5 cm; the mean maximum node size was 9.7±0.7 cm. There were no significant differences in the duration of operations and amount of blood loss in the studied groups (p&gt;0.05).</p><p>The main symbionts of this biotope (lactobacilli) were absent in Group III patients during the bacteriological study of VDPVF. The detection rate (p&lt;0.05) and quantitative characteristics (p&gt;0.05) of these microorganisms were lower in Group II compared to those in Group I (Table 1). The narrower spectrum of microorganisms verified in the VDPVF in Group III, with the absence of not only lactobacilli but also bifidobacteria, peptococci, and yeast-like fungi of the Candida genus, is noteworthy.</p><p>The dominating cluster of anaerobic microorganisms in Groups I and II was Eubacterium spp., and in Group III, Peptostreptococcus spp. The rate of detection of Bacteroides spp. was significantly higher (p&lt;0.05) in Group III compared to the results obtained in Groups I and II. Among the aerobic component of the vaginal microbiocenosis, coagulase-negative staphylococci (CNS) dominated in all groups with a 100.0% detection in Group III. Streptococcus spp. was significantly more frequently (p&lt;0.05) verified in this group (81.3%) compared with the same figures in Groups I and II (42.1% and 50.0%, respectively). Candida yeast-like fungi were absent in the vaginal biotope in Group III but their detection rate was significantly (p&lt;0.05) higher in Group I. E. coli was detected only in patients from Group II. Eubacterium spp., Peptostreptococcus spp., and CNS were the most stable associates of the vaginal biotope in the patients of the studied groups.</p><p>The following circumstance is noteworthy in the analysis of quantitative indices: Group II patients had significantly higher (p&lt;0.05) mean values (median) for Peptostreptococcus spp., Bacteroides spp., Candida spp., and Group III patients had lower (p&lt;0.05) Corynebacterium spp. compared to similar parameters in other groups.</p><p>The bacteriological study of MNs (size ≥5 cm) in patients in the three groups did not reveal microbial growth in 7.2% of cases, which, in the authors’ opinion, is not related to the sterility of these loci but to the lack of technical possibilities of culturing. Microorganisms from MNs were isolated in monovariants (20.8%), as well as in bacterial associations – two-component (57.1%) and three-component (22.1%) ones.</p><p>It should be noted that the MN microbiota was primarily represented by anaerobic taxa (Figure 2). The exception was E.coli that were detected in both MNs and VDPVF in Group II. Peptococcus spp. (68.4%) dominated in the studied locus in Group I, Peptococcus spp. and Peptostreptococcus spp. – in Group II (45.8% and 41.7%, respectively), and Bacteroides spp. – in Group III (56.3%). Propionibacterium spp. were absent in MNs in Group III patients, but they were recorded in VDPVF (31.3%). Veillonella spp. were absent in the VDPVF in the study groups, but they were isolated from the MNs in Groups I and II.</p><fig id="fig-2"><caption><p>Рисунок 2. Микробные паттерны миоматозных узлов в исследуемых группах</p><p>Figure 2. Microbial patterns of myomatous nodes in the studied groups</p></caption><graphic xlink:href="mvjr-13-2-g002.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/mvjr/2022/2/770OtWt9C5YVG5kcNLgTB7BDcJ1hEQOBRjYz3lN8.jpeg</uri></graphic></fig><p>The quantitative characteristics of MN infestation (median) did not differ significantly (p&gt;0.05) in the studied groups, with a mean value (lg 2.0±0.5 CFU/biopsy specimen) and an interquartile range of 2.0 [lower quartile] to 3.0 [upper quartile].</p><p>The bacteriological study of MNBs did not reveal any microbial growth in 17.7%; monovariants were registered in 26.6%, 2-component bacterial associations – in 43.0%, and 3-component or more – in 12.7%. Taxonomic characteristics of microorganisms isolated from MNBs were similar to those isolated from MNs but with some variations in the frequency of detection of certain microbial taxa (Figure 3).</p><fig id="fig-3"><caption><p>Рисунок 3. Микробиота ложа миоматозных узлов в исследуемых группах</p><p>Figure 3. Microbiota of the bed of myomatous nodes in the studied groups</p></caption><graphic xlink:href="mvjr-13-2-g003.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/mvjr/2022/2/8AAVEGA0NnwiD7FK8NVtALPHuy6TyDPDVA3ug18J.jpeg</uri></graphic></fig><p>Peptococcus spp. dominated in the MNB specimens in the studied groups. The rate of Eubacterium spp. detection was significantly (p&lt;0.05) higher in Group III compared to Groups I and II and there were no Propionibacterium spp. and Veillonella spp. The presence of E. coli was similarly recorded only in Group II.</p><p>The bacterial content in MNB (median) samples in the studied groups did not differ significantly (p&gt;0.05), being lg 2.4±0.6 CFU/biopsy specimen.</p><p>The correlation associations (CAs) between microorganisms verified in the loci "vagina – MN", "vagina – MNB" were studied; the significant values are presented in Table 2. The obtained CAs were direct in most cases, and only in Group III, it was reverse for Eubacterium spp. and Peptostreptococcus spp., which indirectly indicates the interrelation between the studied loci. The question arises if the fact of detection of microorganisms in the MN and its bed is associated with an infectious and inflammatory process in the tissues. To answer this question, the authors carried out a morphological study of the biopsy specimens, which proved the absence of an inflammatory tissue reaction (Figures 4, 5).</p><fig id="fig-4"><caption><p>Рисунок 4. Миоматозный узел. Клеточная лейомиома. Опухоль представлена пучками разнонаправленно идущих гладкомышечных волокон. Окраска гематоксилином-эозином. Ув.100</p><p>Figure 4. Myomatous node. Cellular leiomyoma. The tumor is represented by bundles of multidirectional smooth muscle fibers. Stained with hematoxylin-eosin. Magnification 100</p></caption><graphic xlink:href="mvjr-13-2-g004.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/mvjr/2022/2/xioa8y4PDN0ywdxwr6Gzj8oRqbuoc9goJX8aNgen.jpeg</uri></graphic></fig><fig id="fig-5"><caption><p>Рисунок 5. Ложе узла. Пласты мышечных волокон, расположенных в циркулярном и косом направлении. Между мышечной тканью грубоволокнистая соединительная ткань, крупные толстостенные артерии. Окраска гематоксилином-эозином. Ув.100</p><p>Figure 5. Knot bed. Layers of muscle fibers located in the circular and oblique direction. Between the muscle tissue coarse fibrous connective tissue, large thick-walled arteries. Stained with hematoxylin-eosin. Magnification 100</p></caption><graphic xlink:href="mvjr-13-2-g005.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/mvjr/2022/2/BzblJgFFijqZ3WjpAAZQ8hFfouQbO2ahMbmQMbfL.jpeg</uri></graphic></fig><p>It should be noted that Group I, II, and III patients had no infectious-inflammatory complications in the postoperative period.</p></sec><sec><title>Discussion</title><p>Patients in the study groups had multidirectional data on the detection rate of various taxa of the vaginal microbiota, in particular lactobacilli. These microorganisms were absent in patients from Group III who were in the age range of 45–50 years old, i.e. in the premenopause, but whose cluster of anaerobic microorganisms had dominating Bacteroides spp., which agrees with the data published by Muhleisen and Herbst-Kralovetz (2016) [<xref ref-type="bibr" rid="cit26">26</xref>]. Despite the fact that lactobacilli primarily dominate the vaginal biotope and perform a number of positive functions [27, 28], their detection rates were reduced in patients with UFs in Groups I and II. The vaginal microbiota is very plastic and any pathological condition, in particular UFs, changes the compositions of microbial communities in women of different age groups.</p><p>To date, there are data on the microbiota and/or microbiome of the uterus, placenta, fallopian tubes, and ovaries [29–31]. The bacterial taxa that prevail in different types of vaginal microbiota were described [27, 28]. However, the microbiota of MNs remains understudied. The present study only slightly uncovers this intriguing and interesting issue, since the obtained data indicate that MNs and their beds are non-sterile, and there are no signs of an infectious and inflammatory process in this cohort of subjects. However, the scenario of infectious-inflammatory complications can unfold along a different vector, when normal symbionts of the vaginal biotope, MN, and MNB, under certain conditions can be the manifestants of infectious-inflammatory complications.</p><p>Further studies should be aimed at expanding the cohort of subjects of different ages with UFs, including pregnant women with this pathology, by isolating patients, if any, with various infectious-inflammatory complications in the postoperative period, and conducting a comprehensive comparative analysis of the microbiota of the studied loci in the groups with and without complications.</p></sec><sec><title>Conclusion</title></sec></body><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Goldenberg RL, Klebanoff MA, Nugent R, Krohn MA, Hillier S, Andrews ww. Bacterial colonization of the vagina during pregnancy in four ethnic groups. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol. 1996;174(5):1618-21. Doi: 10.1016/s0002-9378(96)70617-8.</mixed-citation><mixed-citation xml:lang="en">Goldenberg RL, Klebanoff MA, Nugent R, Krohn MA, Hillier S, Andrews ww. Bacterial colonization of the vagina during pregnancy in four ethnic groups. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol. 1996;174(5):1618- 21. Doi: 10.1016/s0002-9378(96)70617-8.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Бебнева Т.Н., Летуновская А.Б. Лактобактерии и эстриол в коррекции биоценоза влагалища. Фарматека. 2010;(9):24–28. eLIBRARY ID: 15192731</mixed-citation><mixed-citation xml:lang="en">Bebneva T.N., Letunovskaya A.B. Lactobacillus and estriol in maintenance of vaginal biocenosis. Farmateka. 2010;(9):24–28. (In Russ.). eLIBRARY ID: 15192731</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Климанов А.Ю. Особенности органосохраняющего хирургического лечения миомы матки лапароскопическим доступом у женщин репродуктивного возраста: автореф. дис. … канд. мед. наук. Самара. 2012. – 24 с.</mixed-citation><mixed-citation xml:lang="en">Klimanov A. Yu. Features of organ-preserving surgical treatment of uterine fibroids by laparoscopic access in women of reproductive age: Abstract of the thesis. dis. … Candidate of Medical Sciences. Samara. 2012. - 24 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Gajer P, Brotman RM, Bai G, Sakamoto j, Schütte UM, et al. Temporal dynamics of the human vaginal microbiota. Sci Transl Med. 2012;4(132):132ra52. DOI: 10.1126/scitranslmed.3003605.</mixed-citation><mixed-citation xml:lang="en">Gajer P, Brotman RM, Bai G, Sakamoto j, Schütte UM, et al. Temporal dynamics of the human vaginal microbiota. Sci Transl Med. 2012;4(132):132ra52. DOI: 10.1126/scitranslmed.3003605.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Hickey Rj, Zhou x, Pierson jD, Ravel j, Forney Lj. Understanding vaginal microbiome complexity from an ecological perspective. Transl Res. 2012;160(4):267-82. DOI: 10.1016/j.trsl.2012.02.008.</mixed-citation><mixed-citation xml:lang="en">Hickey Rj, Zhou x, Pierson jD, Ravel j, Forney Lj. Understanding vaginal microbiome complexity from an ecological perspective. Transl Res. 2012;160(4):267-82. DOI: 10.1016/j.trsl.2012.02.008.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Доброхотова Ю.э., Ибрагимова Д.М., Сапрыкина Л.В. Миома матки. М.: ГэОТАР-Медиа, 2018.</mixed-citation><mixed-citation xml:lang="en">Dobrokhotova Yu.E., Ibragimova D.M., Saprykina L.V. Uterine fibroids. Moscow: GEOTAR-Media; 2018. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Доброхотова Ю.э., Ильина И.Ю., Ибрагимова Д.М., Нариманова М.Р. Миома матки: альтернативные методы лечения. Проблемы репродукции. 2018; 24; 2:83-87. DOI: 10.17116/repro201824283-87</mixed-citation><mixed-citation xml:lang="en">Dobrokhotova Yu.E., Ilyina I.Yu., Ibragimova D.M., Narimanova M.R. Uterine fibroids: alternative treatments. Reproduction problems. 2018;24;2:83-87. (In Russ.) DOI: 10.17116/repro201824283-87</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Yu O, Scholes D, Schulze-Rath R, Grafton j, Hansen K, Reed SD. A US population-based study of uterine fibroid diagnosis incidence, trends, and prevalence: 2005 through 2014. Am J Obstet Gynecol. 2018;219(6):591.e1-591.e8. DOI: 10.1016/j.ajog.2018.09.039.</mixed-citation><mixed-citation xml:lang="en">Yu O, Scholes D, Schulze-Rath R, Grafton j, Hansen K, Reed SD. A US population-based study of uterine fibroid diagnosis incidence, trends, and prevalence: 2005 through 2014. Am J Obstet Gynecol. 2018;219(6):591.e1-591.e8. DOI: 10.1016/j.ajog.2018.09.039.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Алтухова О.Б., Радзинский В.Е., Полякова И.С., Чурносов М.И. Роль генов факторов роста в развитии миомы матки в сочетании с гиперплазией эндометрия. Акушерство и гинекология. 2021;4:104-110. DOI: 10.18565/aig.2021.4.104-110</mixed-citation><mixed-citation xml:lang="en">9 Altukhova O.B., Radzinsky V.E., Polyakova I.S., Churnosov M.I. The role of growth factor genes in the development of uterine fibroids in combination with endometrial hyperplasia. Obstetrics and gynecology. 2021; 4:104 - 110. (In Russ.) DOI: 10.18565/aig.2021.4.104-110</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Mäkinen N, Heinonen HR, Moore S, Tomlinson IP, van der Spuy ZM, Aaltonen LA. MED12 exon 2 mutations are common in uterine leiomyomas from South African patients. Oncotarget. 2011;2(12):966-9. DOI: 10.18632/oncotarget.370.</mixed-citation><mixed-citation xml:lang="en">Mäkinen N, Heinonen HR, Moore S, Tomlinson IP, van der Spuy ZM, Aaltonen LA. MED12 exon 2 mutations are common in uterine leiomyomas from South African patients. Oncotarget. 2011;2(12):966-9. DOI: 10.18632/oncotarget.370.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Самсонов А.Е., Рымашевский А.Н., Волков А.Е., Терехина Л.А. Особенности влияния миомы матки на течение беременности. Таврический медикобиологический вестник. 2013;16:2(1):205-207. eLIBRARY ID:22807263</mixed-citation><mixed-citation xml:lang="en">Samsonov A.E., Rymashevsky A.N., Volkov A.E., Terekhina L.A. Features of the effect of uterine fibroids on the course of pregnancy. Tauride Medical and Biological Bulletin. 2013; 16:2(1):205-207. (In Russ.) eLIBRARY ID: 22807263</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Радзинский В.Е., Тотчиев Г.Ф. Миома матки: курс на органосохранение. Информационный бюллетень. М.: Редакция журнала StatusPraesens; 2014.</mixed-citation><mixed-citation xml:lang="en">Radzinsky V.E., Totchiev G.F. Uterine fibroids: a course on organ preservation. News bulletin. Moscow: Editorial staff of Status Praesens; 2014. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Biglia N, Carinelli S, Maiorana A, D'Alonzo M, Lo Monte G, Marci R. Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids. Drug Des Devel Ther. 2014;8:285-92. DOI: 10.2147/DDDT.S54565.</mixed-citation><mixed-citation xml:lang="en">Biglia N, Carinelli S, Maiorana A, D'Alonzo M, Lo Monte G, Marci R. Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids. Drug Des Devel Ther. 2014;8:285-92. DOI: 10.2147/DDDT.S54565.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Киселев В.И., Радзинский В.Е., Шалаев О.Н., Есенеева Ф.М., Полозников А.А., и др. Особенности ДНКметилирования при миоме матки. Молекулярная медицина. 2017;15(3):45-50. eLIBRARY ID:29328837</mixed-citation><mixed-citation xml:lang="en">Kiselev V.I., Radzinsky V.E., Shalaev O.N., Eseneeva F.M., Poloznikov A.A., et al. Characteristics of DNA-methylation in uterine fibroids. Molecular medicine. 2017;15(3):45-50. (In Russ.) eLIBRARY ID:29328837</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Mas A, Tarazona M, Dasí Carrasco j, Estaca G, Cristóbal I, Monleón j. Updated approaches for management of uterine fibroids. Int J Womens Health. 2017;9:607-617. DOI: 10.2147/IjwH.S138982.</mixed-citation><mixed-citation xml:lang="en">Mas A, Tarazona M, Dasí Carrasco j, Estaca G, Cristóbal I, Monleón j. Updated approaches for management of uterine fibroids. Int J Womens Health. 2017;9:607-617. DOI: 10.2147/IjwH.S138982.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Боричева Д.А., Мацарская М.Д., Шеповалова Н.С. Миома матки как следствие гормонального дисбаланса. Синергия Наук. 2018;20:650-663. eLIBRARY ID:32484393</mixed-citation><mixed-citation xml:lang="en">Boricheva D.A., Matsarskaya M.D., Shepovalova N.S. Uterine fibroids as a consequence of hormonal imbalance. Synergy of Sciences. 2018;20:650-663. (In Russ.) eLIBRARY ID:32484393</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Воскресенский С.Л., Грудницкая Е.Н., Тесакова М.Л., Небышинец Л.М., Шорох И.Г., Куницкая О.А. Клинические и гормональные изменения при миоме матки в репродуктивном возрасте. Репродуктивное здоровье Восточная Европа. 2018;8(2):155-162. eLIBRARY ID:32792719</mixed-citation><mixed-citation xml:lang="en">Voskresenskiy S., Grudnitskaya E., Tesakova M., Nebyshinec L., Shoroch I., Kunickaya O. Clinical and hormonal changes in uterine fibroid in a reproductive age. Reproductive health Eastern Europe. 2018;8(2):155-162. (In Russ.) eLIBRARY ID:32792719</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Алтухова О.Б., Радзинский В.Е., Полякова И.С., Чурносов М.И. Вовлеченность полиморфизма генов рецепторов эстрогенов и прогестерона в развитие миомы матки. Акушерство и гинекология. 2020;3:127-132. DOI: 10.18565/aig.2020.3.127-132</mixed-citation><mixed-citation xml:lang="en">Altukhova O.B., Radzinsky V.E., Polyakova I.S., Churnosov M.I. Involvement of estrogen and progesterone receptor gene polymorphisms in the development of uterine fibroids. Obstetrics and gynecology. 2020;3:127-132. (In Russ.) DOI: 10.18565/aig.2020.3.127-132</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ярмолинская М.И., Поленов Н.И., Куница В.В. Миома матки — роль сигнальных путей в патогенезе заболевания (обзор литературы). Журнал акушерства и женских болезней. 2020;69(5):113-124. DOI: 10.17816/jOwD695113-124</mixed-citation><mixed-citation xml:lang="en">armolinskaya M.I., Polenov N.I., Kunitsa V.V. Uterine fibroids: the role of signaling pathways in the pathogenesis. A literature review. Journal of obstetrics and women’s diseases. 2020;69(5):113-124. (In Russ.). DOI: 10.17816/jOwD695113-124</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Reis FM, Bloise E, Ortiga-Carvalho TM. Hormones and pathogenesis of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016;34:13-24. DOI: 10.1016/j.bpobgyn.2015.11.015.</mixed-citation><mixed-citation xml:lang="en">Reis FM, Bloise E, Ortiga-Carvalho TM. Hormones and pathogenesis of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016;34:13-24. DOI: 10.1016/j.bpobgyn.2015.11.015.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Faerstein E, Szklo M, Rosenshein NB. Risk factors for uterine leiomyoma: a practice-based case-control study. II. Atherogenic risk factors and potential sources of uterine irritation. Am J Epidemiol. 2001;153(1):11-9. DOI: 10.1093/aje/153.1.11.</mixed-citation><mixed-citation xml:lang="en">Faerstein E, Szklo M, Rosenshein NB. Risk factors for uterine leiomyoma: a practice-based case-control study. II. Atherogenic risk factors and potential sources of uterine irritation. Am J Epidemiol. 2001;153(1):11-9. DOI: 10.1093/aje/153.1.11.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Sośnik H, jeleń M, Kosiński M, Sośnik K. Research on genesis of adipocytic metaplasia in uterine fibroids. Pol J Pathol. 2015;66(4):403-9. DOI: 10.5114/pjp.2015.57254.</mixed-citation><mixed-citation xml:lang="en">Sośnik H, jeleń M, Kosiński M, Sośnik K. Research on genesis of adipocytic metaplasia in uterine fibroids. Pol J Pathol. 2015;66(4):403-9. DOI: 10.5114/pjp.2015.57254.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Тихомиров А.Л., Гришин Г.П., Лубнин Д.М., Зинин Д.С., Кочарян А.А. Современное органосохраняющее лечение миомы матки. Consilium medicum. 2013;10(6):19–23. eLIBRARY ID: 20267593</mixed-citation><mixed-citation xml:lang="en">Tikhomirov A.L., Grishin G.P., Lubnin D.M., Zinin D.S., Kocharyan A.A. Modern organ-preserving treatment of uterine fibroids. Consilium medicum. 2013;10(6):19–23. (In Russ.) eLIBRARY ID: 20267593</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Табарина Е.П., Потатуркина-Нестерова Н.И. Ассоциация миомы матки с инфицированностью уреаплазмами. Казанский медицинский журнал. 2009; 90(3):408-411. eLIBRARY ID: 12906435</mixed-citation><mixed-citation xml:lang="en">Tabarina E.P., Potaturkina-Nesterova N.I. The association of hysteromyoma with ureoplasm infection. Kazan Medical Journal. 2009; 90(3):408-411. (In Russ.). eLIBRARY ID: 12906435</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Меньшиков В.В. Методики клинических лабораторных исследований: Справочное пособие. Т. 3. М.: Лабора; 2009.</mixed-citation><mixed-citation xml:lang="en">Menshikov V.V. Methods of clinical laboratory research: Reference manual. T. 3. Moscow: Labora; 2009. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Muhleisen AL, Herbst-Kralovetz MM. Menopause and the vaginal microbiome. Maturitas. 2016;91:42-50. DOI: 10.1016/j.maturitas.2016.05.015.</mixed-citation><mixed-citation xml:lang="en">Muhleisen AL, Herbst-Kralovetz MM. Menopause and the vaginal microbiome. Maturitas. 2016;91:42-50. DOI: 10.1016/j.maturitas.2016.05.015.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Kroon Sj, Ravel j, Huston wM. Cervicovaginal microbiota, women's health, and reproductive outcomes. Fertil Steril. 2018;110(3):327-336. DOI: 10.1016/j.fertnstert.2018.06.036.</mixed-citation><mixed-citation xml:lang="en">Kroon Sj, Ravel j, Huston wM. Cervicovaginal microbiota, women's health, and reproductive outcomes. Fertil Steril. 2018;110(3):327-336. DOI: 10.1016/j.fertnstert.2018.06.036.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Peelen Mj, Luef BM, Lamont RF, de Milliano I, jensen jS, et al. The influence of the vaginal microbiota on preterm birth: A systematic review and recommendations for a minimum dataset for future research. Placenta. 2019;79:30-39. DOI: 10.1016/j.placenta.2019.03.011.</mixed-citation><mixed-citation xml:lang="en">Peelen Mj, Luef BM, Lamont RF, de Milliano I, jensen jS, et al. The influence of the vaginal microbiota on preterm birth: A systematic review and recommendations for a minimum dataset for future research. Placenta. 2019;79:30-39. DOI: 10.1016/j.placenta.2019.03.011.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Godha K, Tucker KM, Biehl C, Archer DF, Mirkin S. Human vaginal pH and microbiota: an update. Gynecol Endocrinol. 2018;34(6):451-455. DOI: 10.1080/09513590.2017.1407753.</mixed-citation><mixed-citation xml:lang="en">Godha K, Tucker KM, Biehl C, Archer DF, Mirkin S. Human vaginal pH and microbiota: an update. Gynecol Endocrinol. 2018;34(6):451-455. DOI: 10.1080/09513590.2017.1407753.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Peric A, weiss j, Vulliemoz N, Baud D, Stojanov M. Bacterial Colonization of the Female Upper Genital Tract. Int J Mol Sci. 2019;20(14):3405. DOI: 10.3390/ijms20143405.</mixed-citation><mixed-citation xml:lang="en">Peric A, weiss j, Vulliemoz N, Baud D, Stojanov M. Bacterial Colonization of the Female Upper Genital Tract. Int J Mol Sci. 2019;20(14):3405. DOI: 10.3390/ijms20143405.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Калинкина О.Б., Тезиков Ю.В., Липатов И.С., Аравина О.Р., Морозова О.Н. Исследование микробиоты урогенитального тракта и кишечника у женщин с III-IV стадиями эндометриоза яичников. Пермский медицинский журнал. 2020;37(1):14-21. DOI: 10.17816/pmj37114-21</mixed-citation><mixed-citation xml:lang="en">Kalinkina O.B., Tezikov Y.V., Lipatov I.S., Aravina O.R., Morozova O.N. Study of urogenital tract and gut microbiota in women with stage III and IV ovarian endometriosis. Perm Medical Journal. 2020;37(1):14-21. (In Russ.). DOI: 10.17816/pmj37114-21</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
